Document and Entity Information |
Jan. 10, 2022 |
|---|---|
| Cover [Abstract] | |
| Amendment Flag | true |
| Entity Central Index Key | 0001662579 |
| Document Type | 8-K/A |
| Document Period End Date | Jan. 10, 2022 |
| Entity Registrant Name | C4 THERAPEUTICS, INC. |
| Entity Incorporation State Country Code | DE |
| Entity File Number | 001-39567 |
| Entity Tax Identification Number | 47-5617627 |
| Entity Address, Address Line One | 490 Arsenal Way |
| Entity Address, Address Line Two | Suite 200 |
| Entity Address, City or Town | Watertown |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02472 |
| City Area Code | (617) |
| Local Phone Number | 231-0700 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Security 12b Title | Common Stock, $0.0001 par value per share |
| Trading Symbol | CCCC |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
| Amendment Description | This amendment to Form 8-K is being filed to amend and supplement a Form 8-K filed by C4 Therapeutics, Inc. (the “Company”) on January 10, 2022 (the “Form 8-K”) solely for the purpose of correcting the hyperlink to Exhibit 99.1 contained in Item 9.01 of the Form 8-K. Other than the foregoing, there are no changes to the disclosures provided in the Form 8-K. |